Page 21 - Patrick Wingrove News Today

By Patrick Wingrove PHILADELPHIA (Reuters) - U.S. Food and Drug Administration official Peter Marks said on Wednesday he hopes to align global ...

Amgens battle with Sanofi and Regeneron at the Supreme Court over its cholesterol drug Repatha on Monday has some drugmakers hoping a ruling will reshape US patent law and competition among companies that make antibody medicines.

Modernas chief executive on Wednesday defended the companys plan to quadruple the price of its COVID-19 vaccine, telling a US Senate committee hearing it will no longer have the economies of scale from government procurement when the shots move into the private market.

By Patrick Wingrove (Reuters) -Moderna Inc expects to price its COVID-19 vaccine at around $130 per dose in the U.S. going forward as purchases move t...

(Reuters) - Sanofi SA said on Thursday it would cut U.S. list prices by 78% for its most-prescribed insulin product starting next year, following riva...

Sanofi said on Thursday it will cut US list prices for its most-prescribed insulin product, Lantus, by 78% starting next year after similar moves by rivals Novo Nordisk and Eli Lilly.

The collapse of Silicon Valley Bank will leave early-stage biotechnology companies with a funding void, investors and analysts said on Monday, but larger, publicly-traded drug companies should... | March 13, 2023

The collapse of Silicon Valley Bank will leave early stage biotechnology companies with a funding void, investors and analysts said on Monday, but larger, publicly traded drug companies should escape unscathed.

The White House budget request includes plans to strengthen the FDA’s regulatory authority.

The blood thinner Eliquis from Bristol Myers Squibb, Pfizers breast cancer drug Ibrance and AbbVies leukemia treatment Imbruvica are likely to be among 10 big-selling medicines subject to U.S.... | March 13, 2023